Braskem (BAK) Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAK, but not buy additional shares or sell existing shares.
View BAK analyst ratings or view top-rated stocks.

6 equities research analysts have issued 12-month price targets for Braskem's stock. Their BAK share price forecasts range from $16.75 to $16.75. On average, they expect the company's stock price to reach $16.75 in the next twelve months. This suggests a possible upside of 71.3% from the stock's current price.
View analysts price targets for BAK or view top-rated stocks among Wall Street analysts.

Braskem's stock was trading at $9.20 on January 1st, 2023. Since then, BAK shares have increased by 6.3% and is now trading at $9.78.
View the best growth stocks for 2023 here.

Braskem saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 692,100 shares, an increase of 192.1% from the April 30th total of 236,900 shares. Based on an average daily trading volume, of 1,180,000 shares, the short-interest ratio is currently 0.6 days.
View Braskem's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our BAK earnings forecast.

Braskem S.A. (NYSE:BAK) posted its quarterly earnings results on Thursday, March, 23rd. The company reported ($0.82) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.09) by $0.27. The business had revenue of $3.61 billion for the quarter, compared to the consensus estimate of $3.55 billion. Braskem had a negative trailing twelve-month return on equity of 56.42% and a negative net margin of 4.53%.

ETFs with the largest weight of Braskem (NYSE:BAK) stock in their portfolio include Virtus Real Asset Income ETF (VRAI).Avantis Emerging Markets Value ETF (AVES).

31 employees have rated Braskem Chief Executive Officer Roberto Lopes Pontes Simões on Glassdoor.com. Roberto Lopes Pontes Simões has an approval rating of 100% among the company's employees. This puts Roberto Lopes Pontes Simões in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN), Enterprise Products Partners (EPD), Micron Technology (MU), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Aduro Biotech (ADRO), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP) and Chevron (CVX).

Braskem trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAK."

Braskem's stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.11%), Two Sigma Investments LP (0.09%), State Street Corp (0.04%), Verdad Advisers LP (0.03%), Bank of America Corp DE (0.03%) and Squarepoint Ops LLC (0.02%).

Shares of BAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BAK stock can currently be purchased for approximately $9.78.

Braskem (NYSE:BAK) has a market capitalization of $4.42 billion and generates $18.69 billion in revenue each year. The company earns $-65,020,000.00 in net income (profit) each year or ($1.98) on an earnings per share basis.

The company employs 8,668 workers across the globe.

Braskem's mailing address is Rua Lemos Monteiro 120 24 andar, Butanta D5, 05501-050. The official website for the company is www.braskem.com.br. The company can be reached via phone at 551135769735, via email at braskem-ri@braskem.com, or via fax at 55-11-3576-9532.